- Home
- VINP vs ORIC Comparison
VINP vs ORIC Comparison
Compare VINP & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINP
- ORIC
- Stock Information
- Founded
- VINP 2009
- ORIC 2014
- Country
- VINP Brazil
- ORIC United States
- Employees
- VINP N/A
- ORIC N/A
- Industry
- VINP Investment Managers
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- VINP Finance
- ORIC Health Care
- Exchange
- VINP Nasdaq
- ORIC Nasdaq
- Market Cap
- VINP 641.7M
- ORIC 633.7M
- IPO Year
- VINP 2021
- ORIC 2020
- Fundamental
- Price
- VINP $9.45
- ORIC $8.60
- Analyst Decision
- VINP Strong Buy
- ORIC Strong Buy
- Analyst Count
- VINP 2
- ORIC 9
- Target Price
- VINP $13.50
- ORIC $18.75
- AVG Volume (30 Days)
- VINP 95.0K
- ORIC 483.1K
- Earning Date
- VINP 02-05-2025
- ORIC 11-12-2024
- Dividend Yield
- VINP 5.81%
- ORIC N/A
- EPS Growth
- VINP N/A
- ORIC N/A
- EPS
- VINP 0.60
- ORIC N/A
- Revenue
- VINP $88,217,697.00
- ORIC N/A
- Revenue This Year
- VINP $17.23
- ORIC N/A
- Revenue Next Year
- VINP $51.06
- ORIC N/A
- P/E Ratio
- VINP $15.54
- ORIC N/A
- Revenue Growth
- VINP 9.03
- ORIC N/A
- 52 Week Low
- VINP $9.01
- ORIC $6.33
- 52 Week High
- VINP $11.85
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- VINP 34.30
- ORIC 47.82
- Support Level
- VINP $9.45
- ORIC $7.86
- Resistance Level
- VINP $10.14
- ORIC $9.47
- Average True Range (ATR)
- VINP 0.28
- ORIC 0.53
- MACD
- VINP -0.07
- ORIC 0.05
- Stochastic Oscillator
- VINP 18.86
- ORIC 47.29
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.